Review of smoking cessation treatments for people with mental illness

Campion, Jonathan; Checinski, Ken; Nurse, Jo

doi:10.1192/apt.bp.107.003483

Cited by 32 publications

(23 citation statements)

References 57 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Many individuals with schizophrenia want to stop smoking and can be helped to do so, though interventions may have to be tailored to take account of issues such as the effect of nicotine on drug metabolism [34]. There is no evidence that these interventions, have reduced the rate of smoking in the population of people with schizophrenia and more practical research is needed.…”

Section: Other Predictors Of Mortalitymentioning

confidence: 99%

Predictors of death from natural causes in schizophrenia: 10-year follow-up of a community cohort

Brown

Mitchell

2011

Soc Psychiatry Psychiatr Epidemiol

View full text Add to dashboard Cite

show abstract

Section: Other Predictors Of Mortalitymentioning

confidence: 99%

Predictors of death from natural causes in schizophrenia: 10-year follow-up of a community cohort

Brown

Mitchell

2011

Soc Psychiatry Psychiatr Epidemiol

View full text Add to dashboard Cite

show abstract

“…Some staff may see a conflict between doing greatest good for the majority through a smoke-free policy, and an attempt to respond to individual need when dealing with distressed, non-comprehending individuals in crisis (Campion et al, 2008a). Such conflicts can be divisive and have a strong emotional impact on staff, which can contribute to the inconsistent application of a smoke-free policy.…”

Section: Difficulties Introducing Smokefree Policies In Mental Healthmentioning

confidence: 99%

Smoking by people with mental illness and benefits of smoke-free mental health services

Campion¹,

Checinski²,

Nurse³

et al. 2008

Adv. psychiatr. treat

Self Cite

View full text Add to dashboard Cite

Smoking is the largest single cause of preventable illness in the UK. Those with mental health problems smoke significantly more and are therefore at greater risk. The new Health Act (2006) will require mental health facilities in England to be completely smoke-free by 1st July 2008. This article reviews the current literature regarding how smoking affects both the physical and mental well-being of people with mental health problems. It also considers the effects of smoke-free policy in mental health settings.Jonathan Campion is a specialist psychiatry registrar on the St George's Psychiatry Training Scheme in London

show abstract

“…22 A review of cessation treatments for outpatients with mental illness concluded that for depressed smokers, cognitive-behavioral and nicotine replacement therapy (NRT) doubled cessation rates and reduced depressive symptoms. 23 Notably, the combination of NRT and buproprion resulted in more abstinence than NRT alone among smokers with schizophrenia. 24 Together the evidence suggests that pharmacotherapy and psychological counseling are effective in helping people with mental illness to quit smoking.…”

Section: Introductionmentioning

confidence: 99%

Treating Tobacco Dependence at the Intersection of Diversity, Poverty, and Mental Illness: A Randomized Feasibility and Replication Trial

Hickman¹,

Delucchi

Prochaska

2015

NICTOB

View full text Add to dashboard Cite

Introduction: In an ethnically-diverse, uninsured psychiatric sample with co-occurring drug/alcohol addiction, we evaluated the feasibility and reproducibility of a tobacco treatment intervention. The intervention previously demonstrated efficacy in insured psychiatric and nonpsychiatric samples with 20.0%-25.0% abstinence at 18 months. Methods: Daily smokers, recruited in 2009-2010 from psychiatric units at an urban public hospital, were randomized to usual care (on-unit nicotine replacement plus quit advice) or intervention, which added a Transtheoretical-model tailored, computer-assisted intervention, stage-matched manual, brief counseling, and 10-week post-hospitalization nicotine replacement. Results: The sample (N = 100, 69% recruitment rate, age M = 40) was 56% racial/ethnic minority, 65% male, 79% unemployed, and 48% unstably housed, diagnosed with unipolar (54%) and bipolar (14%) depression and psychotic disorders (46%); 77% reported past-month illicit drug use. Prior to hospitalization, participants averaged 19 (SD = 11) cigarettes/day for 23 (SD = 13) years; 80% smoked within 30 minutes of awakening; 25% were preparing to quit. Encouraging and comparable to effects in the general population, 7-day point prevalence abstinence for intervention versus control was 12.5% versus 7.3% at 3 months, 17.5% versus 8.5% at 6 months, and 26.2% versus 16.7% at 12 months. Retention exceeded 80% over 12 months. The odds of abstinence increased over time, predicted by higher self-efficacy, greater perceived social status, and diagnosis of psychotic disorder compared to unipolar depression. Conclusions: Findings indicate uninsured smokers with serious mental illness can engage in tobacco treatment research with quit rates comparable to the general population. A larger investigation is warranted. Inclusion of diverse smokers with mental illness in clinical trials is supported and encouraged.

show abstract

Review of smoking cessation treatments for people with mental illness

Cited by 32 publications

References 57 publications

Predictors of death from natural causes in schizophrenia: 10-year follow-up of a community cohort

Predictors of death from natural causes in schizophrenia: 10-year follow-up of a community cohort

Smoking by people with mental illness and benefits of smoke-free mental health services

Treating Tobacco Dependence at the Intersection of Diversity, Poverty, and Mental Illness: A Randomized Feasibility and Replication Trial

Contact Info

Product

Resources

About